Ikonisys S.A. (EPA:ALIKO)
France · Delayed Price · Currency is EUR 1.500
0.00 (0.00%)
Jun 12, 2026, 5:10 PM CET
Ikonisys Revenue
In the year 2025, Ikonisys had annual revenue of 1.64M EUR with 62.23% growth. Ikonisys had revenue of 761.02K in the half year ending June 30, 2025, with 490.35% growth.
Revenue
1.64M
Revenue Growth
+62.23%
P/S Ratio
14.49
Revenue / Employee
109.35K
Employees
15
Market Cap
23.76M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.64M | 629.20K | 62.23% |
| Dec 31, 2024 | 1.01M | 365.94K | 56.72% |
| Dec 31, 2023 | 645.17K | 28.31K | 4.59% |
| Dec 31, 2022 | 616.87K | 74.17K | 13.67% |
| Dec 31, 2021 | 542.70K | 57.53K | 11.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Eurobio Scientific Société anonyme | 168.60M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 52.86M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Bluelinea Société Anonyme | 11.12M |